PRAC Antikörper (N-Term)
Kurzübersicht für PRAC Antikörper (N-Term) (ABIN926529)
Target
Alle PRAC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- PRAC antibody was raised in rabbit using the N terminal of PRAC as the immunogen
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator.
-
Kommentare
-
PRAC Blocking Peptide, (ABIN937516), is also available for use as a blocking control in assays to test for specificity of this PRAC antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Andere Bezeichnung
- PRAC
-
Hintergrund
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus. Synonyms: Polyclonal PRAC antibody, Anti-PRAC antibody, prostate cancer susceptibility candidate antibody, C17orf92 antibody, MGC32520 antibody.
Target
-